Navigation Links
PAREXEL Reports First Quarter Fiscal Year 2011 Financial Results
Date:11/1/2010

intends," "appears," "estimates," "projects," "will," "would," "could," "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.  Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-K for the quarter ended June 30, 2010 as filed with the SEC on August 27, 2010 which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the futu
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PAREXEL Consulting Releases Annual Analysis of FDA New Drug Review Trends
2. PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum
3. PAREXEL Opens New Office in Japan and Further Strengthens Leading Presence in Asia/Pacific Region
4. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
5. PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers
6. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
7. PAREXEL Introduces Temperature Recording Solution for Study Drug Transportation, Bringing More Efficiency to Clinical Supply Chain
8. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
9. PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument
10. PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
11. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
(Date:7/10/2014)...  RESMED INC. (NYSE: RMD ) today announced ... ended June 30, 2014 results on Thursday, July 31, 2014, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... , NEW YORK, Dec. 2 ... available in its catalogue: , Pharmaceutical Contract ... http://www.reportlinker.com/p0164248/Pharmaceutical-Contract-Manufacturing---Global-Market-Trends.html , Global pharma industry ... in generic markets, rising cost of new product development, ...
... , JUPITER, Fla., Dec. 2 Jupiter Medical ... diagnostic tools available into its imaging program, the new Signa ... highly detailed images of the human body with increased speed, ... non-contrast vascular imaging for patients with renal dysfunction. This ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2
(Date:7/12/2014)... United Arab Emirates (PRWEB) July 12, 2014 ... another Los Angeles basketball legend is heading to the ... scorer and six-time champion will be in the UAE ... & Fitness Weekend in support of diabetes awareness. The ... an award-winning entertainment marketing and event management company based ...
(Date:7/12/2014)... Los Angeles, CA (PRWEB) July 12, 2014 ... a buyer power score of 4.1 out of ... the market that have been underpinning buyer negotiation ... to IBISWorld procurement analyst Anna Son, “during the ... along with rising costs associated with new product ...
(Date:7/11/2014)... (PRWEB) July 12, 2014 Recently, DressyQuinceanera.com, ... 200 Quinceanera Dama dresses to its online ... items are offered at deeply discounted rates, up to ... from DressyQuinceanera.com are equally excellent in terms of quality ... carefully handmade. Similar discounts are also offered for the ...
(Date:7/11/2014)... Lewisberry, PA (PRWEB) July 11, 2014 Butler ... line of Inclined Platform Lifts . Previously the ... now offering five new beautiful earth tone colors as standard ... only blend well in the home but will enhance the ... color choice for any home color scheme or individual décor. ...
(Date:7/11/2014)... July 11, 2014 Microbiology testing is ... in-vitro diagnostics industry, which is expected to pose the ... The sector owes its growth to the ongoing spread ... health worldwide and a major factor leading to the ... of bio-terrorism, and a broader availability of immunosuppressants, among ...
Breaking Medicine News(10 mins):Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:DressyQuinceanera.com: Beautiful Quinceanera Dama Dresses At Low Prices 2Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3
... 113 children and teens physically victimized by peers concludes ... and diffuse threats makes them far less likely to ... immediate aftermath of the attack. , The research, by ... Medical Center in Washington, D.C., was conducted on 10- ...
... The International Diabetes,Federation (IDF) announced today that Ms ... Officer/Executive Director., The International Diabetes Federation, headquartered ... 200 diabetes associations,worldwide. It is the global advocate ... their families, and healthcare providers., Ms Keeling ...
... home safety review could cut odds of fractures in those ... Former first lady Nancy Reagan and Democratic presidential candidate ... And on Friday, author Studs Terkel died, following reports that ... Such news, experts say, should be a reminder to all ...
... study shows that an imaging technology developed by Mayo ... and help eliminate the need for liver biopsies. ... to incurable cirrhosis if not treated in time. , ... images known as elastograms that indicate how internal organs, ...
... health care coverage, yet oppose a government mandate to do so, a ... candidates’ health care proposals. , ... New York, NY (PRWEB) November 1, ... health care coverage, yet oppose a government mandate to do ...
... study in the Nov. 1 issue of the journal ... specific neurochemical abnormality in adults with primary insomnia, providing ... pathology. , Results indicate that gamma-aminobutyric acid (GABA), ... reduced by nearly 30 percent in individuals who have ...
Cached Medicine News:Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 3Health News:New Chief Executive Officer Joins International Diabetes Federation 2Health News:Falls Are Leading Cause of Injury to Seniors 2Health News:Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease 2Health News:Employers “Vote” on Presidential Candidates' Health Care Platforms: Prefer Middle Ground Between the Two Approaches 2Health News:Employers “Vote” on Presidential Candidates' Health Care Platforms: Prefer Middle Ground Between the Two Approaches 3Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 2Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: